ABSTRACT: Acute aortic dissection (AAD) is a life-threatening condition associated with high morbidity and mortality rates, and it remains a challenge to diagnose and treat. The International Registry of Acute Aortic Dissection was established in 1996 with the mission to raise awareness of this condition and provide insights to guide diagnosis and treatment. Since then, >7300 cases have been included from >51 sites in 12 countries. Although presenting symptoms and physical findings have not changed significantly over this period, the use of computed tomography in the diagnosis has increased, and more patients are managed with interventional procedures: surgery in type A AAD and endovascular therapy in type B AAD; with these changes in care, there has been a significant decrease in overall in-hospital mortality in type A AAD but not in type B AAD. Herein, we summarized the key lessons learned from this international registry of patients with AAD over the past 20 years. 
A cute aortic dissection (AAD) is a rare, life-threatening condition that remains a challenge to diagnose and treat. The International Registry of Acute Aortic Dissection (IRAD) was established in 1996 for the purpose of enrolling a large number of patients at a number of aortic centers to assess the presentation, management, and outcomes of AAD. Data on demographics, presenting history, physical examination, imaging studies, management, and outcomes were collected by each referral center ( Figure I in the online-only Data Supplement) and entered on case report forms covering 350 variables using standard definitions and methods. These forms were analyzed by the IRAD Coordinating Center at the University of Michigan 1 for face validity and then entered into a secure online database. Since the first publication in 2000 with the participation of 12 large referral centers in 6 countries, the IRAD has expanded to 51 active sites in 12 countries in North America, Europe, Asia, and Australia. IRAD investigators have published >80 articles derived from the large database of patients with AAD of >7300 cases, thus far, to raise awareness of this difficult-todiagnose entity and provide insights regarding optimal diagnosis and management. This review will cover most of these points, highlighting the critical findings of the IRAD that have been published over these past 2 decades.
DEMOGRAPHICS AND RISK FACTORS
In the IRAD series, 67% of patients presented with type A AAD, with the remaining 33% type B. Two-thirds of included patients were men, with a mean age of 63 years. A number of risk factors were related to aortic dissection, with hyperten-sion (76.6%) being the most common (Table 1) .
1,2 A history of atherosclerosis was present in 27% of patients, known aortic aneurysm in 16%, previous cardíac surgery in 16%, Marfan syndrome in 5%, and an iatrogenic cause in 4% 3 ; cocaine use was implicated in 1.8% of patients. 4, 5 Analysis of the young patients with AAD (<40 years of age) revealed that younger patients were less likely to have a history of hypertension (34%) or atherosclerosis (1%), but more likely to have Marfan syndrome or bicuspid aortic valve (59%). 6 Black patients presented with a higher prevalence of type B AAD (52.4%), were younger, and more frequently had a history of hypertension (89.7%), diabetes mellitus (13.2%), or cocaine abuse (12%) in comparison with white patients. 7 Although ascending aortic dilation is a well-established risk factor for AAD, an interesting finding of the registry was that 60% of patients had maximum aortic diameters <5.5 cm and 40% of patients had aortic diameters <5.0 cm. 8 Although the current surgical guidelines for thoracic aortic aneurysm repair (≥5.5 cm) are designed to mitigate risk of AAD in patients at higher risk for dissection, it would fail to prevent most of the AAD seen in this cohort. It is important to note that smaller aortic size does not preclude AAD. In comparison with the group with aortic diameters of <5.5 cm, the cohort with larger diameters included more patients with Marfan syndrome, bicuspid aortic valve, and history of prior coronary artery bypass surgery. A possible explanation for this disparity is that AAD can be caused by different mechanisms, and aortic diameter could play a crucial role in the presence of genetic disorders, aortic valve flow abnormalities, or aorta wall weakness after surgical trauma from cannulation or cross clamping, but aortic dilation may have a less important role in patients with arterial hypertension. Similarly, only 18.4% of patients with type B AAD had an aortic diameter ≥5.5 cm, 9 and in 21% of patients the maximum aortic diameter was <3.5 cm. 10 Nevertheless, little is known about aortic size immediately before dissection. The presumption has been that the size of the aorta was, if anything, smaller before than after dissection. 
CHRONOBIOLOGICAL PATTERNS
AAD, similar to a variety of cardiovascular disorders, demonstrates chronobiological rhythms. A significantly higher frequency of AAD occurred from 6:00 am to 12:00 noon than in other time periods, with a peak between 8:00 am and 9:00 am (P<0.001). 11 Although no significant variation was found for the day of the week, the frequency of AAD was significantly higher in winter (P<0.008 versus other seasons). Fourier analysis confirmed this monthly variation with a peak in January (P<0.001).
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SIGNS AND SYMPTOMS
The sudden onset of severe chest or back pain was the most frequent symptom. Chest pain was more common in patients with type A dissection (79% versus 63% of type B dissections), whereas back pain was more common in type B dissections (43% versus 64%, respectively). 1 However, tearing, ripping, or migratory were not common descriptors of pain in the IRAD. One interesting observation was that patients who present primarily with acute abdominal pain alone (4.6%) tended to have a delayed diagnosis and had higher mortality than those with more typical symptoms. 14 We believe this occurs because clinicians are less familiar with this atypical presentation. Another possible reason for this higher mortality is malperfusion of the visceral branches originating from the abdominal aorta which is not always easy to establish. Similarly, those with painless AAD (6.3%) had more syncope, congestive heart failure or stroke, and a higher mortality risk. 15 Syncope was reported in 13% of overall cases, and in 19% of type A AAD, often indicating a severe complication such as cardiac tamponade, obstruction of cerebral vessels, or stroke. 16 Hypertension at presentation was more frequent in type B than in type A (70% versus 36%).
1,2 A diastolic murmur of aortic insufficiency was present at the time of presentation in 40% of type A dissections, 1,2 hypotension in >25%, 17 and congestive heart failure in 6%. 18 Pulse deficits were detected in 30% of type A and 20% of type B AAD. It is interesting to note that >50% of patients with pulse deficits had weak or absent pulsations in >1 vessel. 19 Therefore, absence of the classically described physical findings of aortic regurgitation and pulse deficit does not rule out the diagnosis of AAD.
DIAGNOSIS
It is classically accepted that untreated patients with AAD have an associated mortality rate of 1% to 2% per hour immediately after symptom onset. Thus, timely diagnosis is essential for successful management. Nevertheless, it is known that the relative infrequency of AAD, coupled with clinical presentations that may mimic more common problems such as angina pectoris, myocardial infarction, vascular embolization, and abdominal conditions, can impede prompt establishment of the AAD diagnosis. [20] [21] [22] Therefore, the diagnosis of this disease requires a high degree of suspicion of an aortic dissection in patients who have ≥1 risk factors. An IRAD study showed the high sensitivity (>95%) of the clinical risk markers (high-risk conditions, presenting symptoms, and physical examination findings) proposed in the 2010 American Heart Association/American College of Cardiology Thoracic Aortic Disease guidelines 23 to be a tool for the detection of AAD. Those markers include Marfan syndrome, family history of aortic disease, known aortic valve disease, recent aortic manipulation, known thoracic aortic disease, abrupt onset of pain, severe pain intensity, ripping or tearing pain; pulse deficit or systolic blood pressure differential, hypotension or shock state, and focal neurological deficit or murmur of aortic insufficiency, both in conjunction with pain. With the use of the clinical risk markers proposed in the 2010 American Heart Association/American College of Cardiology Thoracic Aortic Disease guidelines by focusing on specific high-risk predisposing conditions, pain features, and physical examination findings, most patients (59.2%) were identified as high risk (score 2 or 3), followed by 36.5% as intermediate risk (score 1) and 4.3% as low risk (score 0).
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Electrocardiogram
An ECG (is routinely performed when patients present with chest pain; it reflects abnormal findings in 30% of patients in whom an abnormal ECG may result from hypertensive changes, compromise of coronary ostia, or preexisting coronary artery disease. 1 In the IRAD series, the ECG showed nonspecific ST and T-wave changes in 42%, ischemic changes in 15%, and evidence of an acute myocardial infarction in 5% of type A AAD. It is not surprising that an abnormal ECG leads to delays in diagnosis, 25 because clinicians often pursue coronary disease as a primary diagnosis because it is so much more prevalent.
Chest X-Ray
Obtaining a chest x-ray is standard in patients presenting with chest pain. However, clinicians may be falsely reassured by a normal chest x-ray, and, thus, the diagnosis of dissection is delayed in this group. 25 Although typical radiographic findings of type A AAD include widening of the mediastinum or aortic knob, in fact, >20% of patients with confirmed AAD lacked abnormalities of the mediastinum or aortic contour. 1 This is particularly likely to occur in patients with a dissection with a nondilated aorta. The relatively nonspecific find- ing of a pleural effusion was seen particularly in those with longer times to diagnosis. 25 
STATE OF THE ART
Imaging Studies
Given the frequency of missed dissections, atypical presentations, and time-dependent morbidity and mortality, effective imaging is paramount in the diagnosis and treatment of this disorder. In the IRAD, the initial diagnostic study was computed tomography in 69% of cases (Figure 1) , echocardiography in 25% (Figure 2 ), MRI in 4%, and aortography in 2% to 3%. Increased availability and faster scanning may account for the greater use of computed tomography. 26 The use of transesophageal echocardiography as the initial diagnostic imaging study has waned over time. 2 North American centers performed an average of 1.6 imaging studies per patient in comparison with 1.8 in the European centers (P=0.002). However, no significant differences in early mortality rates were observed between groups. 27 Some imaging findings not only provided significant diagnostic information, but also had prognostic value and were useful for improving management strategy. 28 Preoperative coronary arteriography was infrequently performed in patients with AAD (11%) except, on occasions, in those at high risk for or with confirmed myocardial ischemia. When performed, it was not associated with any significant changes in inhospital and long-term mortality.
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Biomarkers
Although preliminary evidence suggests a possible diagnostic role for plasma biomarkers, aside from the d-dimer, other tests such as smooth muscle proteins, myosin heavy chain, and creatine kinase BB-isozyme, are not yet available or routinely used in emergency departments. dDimer was markedly elevated in patients with AAD. 30.31 The widely used cutoff level of 500 ng/mL for ruling out pulmonary embolism can also reliably rule out aortic dissection, with a negative likelihood ratio of 0.07 over the first 24 hours. 31 Intramural hematoma, a distinct subentity that shows bleeding limited to the vessel wall with lack of communication with the aortic lumen, but also with an outcome similar to AAD, may not always show elevations, although the exact sensitivity for this subset of acute aortic syndromes remains to be established. d-Dimer levels may also be elevated in chronic stages of aortic dissection (AD) in which the coagulatory response is activated because of the thrombotic process in the false lumen but with unrelated chest pain. Therefore, d-dimer levels may be particularly useful to rule out AAD if used within the first 24 hours after symptom onset.
DIAGNOSIS DELAY AND DIAGNOSTIC STRATEGIES
Median time elapsed from arrival at the emergency department to diagnosis was 4.3 hours (quartile 1-3, 1.5-24 hours). Delays in AAD diagnosis occurred more often in female patients, in those with atypical symptoms that were not sudden or did not include pain, 15, 24 those with previous cardiac surgery, 32 or those who initially attended a nontertiary care hospital (all P<0.05). 25 Critically ill patients with hypotension, tamponade, signs of lower limb ischemia (as evidenced by pulse deficits), coma, or altered consciousness were diagnosed earlier. Dissection was more rapidly diagnosed when computed tomography or echocardiography formed part of the diagnostic workup. In contrast, when MRI or an aortogram were performed, the diagnosis was delayed, often significantly. 25 This may be because of the more subtle or complicated presentations in patients who required those additional imaging strategies.
A new time classification of AD has been proposed by the IRAD. When survival curves were constructed, 4 distinct time periods were noted: hyperacute (symptom onset to 24 hours), acute (2-7 days), subacute (8-30 days), and chronic (>30 days). The overall survival rate was progressively lower through the 4 time periods. 33 This new classification better reflects the different evolutive phrases of acute aortic syndromes in relation to the mortality rate of these patients.
MANAGEMENT AND MORTALITY
Overall mortality for AAD in the first IRAD publication was 27.4% (1). Management and mortality differed significantly depending on whether AAD was type A or type B and on medical or surgical treatment (Figure 3) . 33 
Type A
The majority of patients presenting with type A AAD were managed surgically (86% in the entire series), with significantly more operative procedures undertaken in recent years, rising from 79% in the late 1990s to 90% today. 2 Over time, the in-hospital mortality rate of patients presenting with type A AAD dropped significantly from 31% to 22%, mainly because of a decline in surgical mortality from 25% to 18% (Figure 4) . 2 The medical mortality rate among those with type A AAD remained high (57%) and did not change over time. This is probably an underestimation of overall dissection-related mortality given that >60% of IRAD patients are transferred from outside facilities. Patients who die at the transferring facility or en route are not captured in the IRAD. Therefore, patients who reached an IRAD facility alive had already undergone an element of selection. The mean interval from diagnosis to surgical intervention was 4.3 hours (Q1-Q3, 2.4-14 hours). 25 Similar to the diagnostic delay, the delay in time from diagnosis to surgery was associated with a history of previous cardiac surgery, presentation without abrupt or any pain, and initial presentation to a nontertiary care hospital. It is not surprising that the time period was shorter in unstable patients than in stable patients and suggests that the major predictors of death, such as tamponade and shock, also forced the surgeon to operate sooner on the most critical patients.
In the IRAD series, a conservative aortic repair (supracoronary ascending aorta replacement) was performed in 59% of patients. More extensive aortic resections involving aortic root replacement were performed in 34% of patients (aortic valve-sparing procedure 6%, composite root replacement 16%), proximal hemiarch in 27%, and total arch replacement in 12%. An open procedure with hypothermic circulatory arrest was used in 92% of patients, with cerebral perfusion in 51%. 34 Results demonstrated that a full aortic root replacement did not increase hospital mortality (propensity score-adjusted odds ratio [OR], 1.14) in comparison with more conservative root treatment. 35 However, in a recent publication, it was shown that postoperative myocardial infarction (2.6%) had a high in-hospital mortality (57.9% versus 16.3%, P<0.001) and this complication was more frequent in patients who underwent aortic root replacement (4.4% versus 1.9%), in those who underwent coronary artery bypass grafting (9.6% versus 2.1%), or in those with longer circulatory arrest times.
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Type B
Overall in-hospital type B mortality was 13%, with most deaths occurring within the first week. In the whole registry, 63% of patients with type B AAD were treated medically. In the past 20 years, this percentage has fallen from 75% to 57% as endovascular management has increased from 7% to 31% of cases. 2 Open surgery decreased from 17% to 8%, although there was an increase in hybrid procedures that used surgical debranching techniques to facilitate endovascular intervention. One-third of patients with acute type B dissection presented with complications such as malperfusion syndromes, signs of imminent rupture, expansion, and hemodynamic instability. Endovascular treatment has emerged over the past decade and now exceeds conventional open surgery as the preferred treatment modality for most of these cases. 37 The overall in-hospital mortality rate of patients presenting with type B AAD has not changed significantly (12% versus 14%) in the past 20 years (Figure 4) . 38, 39 Overall mortality of open surgery was 30% versus 10% when patients were treated with medical therapy alone. 2 The 2 independent predictors of surgical mortality of type B AAD were age >70 years (OR, 4.3) and preoperative shock/hypotension (OR, 6.0). 40 In-hospital mortality was significantly higher after open surgery (33.9%) than after endovascular treatment (10.6%, P=0.002). 41 Therefore, in the IRAD, endovascular treatment was associated with better short-term outcomes in terms of mortality and as- sociated complications than open repair; however, as a nonrandomized study, this requires validation in other studies with proper risk adjustment. Also, not all patients with complicated type B dissection have a suitable anatomy for stent graft treatment.
Aortic arch involvement was present in 16% of patients with type B AAD; one-third of these patients were managed by surgery or endovascular treatment. Patients treated with medical therapy alone or endovascular treatment had lower in-hospital mortality than patients treated surgically (8.8% and 9.1% versus 30.8%, respectively; P<0.001). 41 Mortality in the acute phase did not differ between patients with type B dissection treated medically with or without arch involvement. 41, 42 These findings suggest that patients presenting with acute type B dissection with retrograde arch extension might be treated in a similar fashion to those without retrograde arch extension. Isolated abdominal AAD was rare (1.3%), had iatrogenic etiology in 11% (cardiac catheterization), and had a profile similar to the rest of type B AAD.
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COMPLICATIONS
AAD may cause a number of complications that have diagnostic, prognostic, and management implications.
Hypotension and Shock
At hospital presentation, one of the most ominous findings on physical examination is hypotension (systolic blood pressure <90 mm Hg). Hypotension was present in >25% of patients and was associated with neurological deficits, altered mental status, myocardial and mesenteric ischemia, limb ischemia, or death in 55% of patients. 17 Shock occurred in 15% of type A AAD and was associated with higher in-hospital mortality rates (30.2% versus 23.9%, P=0.007). 44 It is interesting to note that the 5-year survival rate of patients with shock in the acute phase who were discharged was similar to that of patients without shock. This underlines the importance not only of timely diagnosis before hemodynamic instability develops, but also of early identification of conditions more likely to cause shock (ie, cardiac tamponade, pleural effusion, severe aortic regurgitation, myocardial ischemia). Early surgical treatment, along with correction of some of the underlying pathophysiological mechanisms of shock described above, may prevent the development of shock and, hence, improve outcome in these patients. Conservative medical management was associated with extremely poor prognosis.
Recurrent Pain and Refractory Hypertension
Both were associated with increased in-hospital mortality in patients with type B dissection (17.4% versus 4%), in particular, when managed medically. 45 Multivariable analysis confirmed the presence of 1 of these 2 variables as a predictor of mortality, with an OR of 3.3.
Pericardial Effusion and Tamponade
Pericardial tamponade was detected in 18% of type A AAD. 46 Those with pericardial tamponade had previous heart surgery less often (7% versus 17%, P=0.007) because the pericardial space would be obliterated by adhesions. Patients with pericardial effusion were more likely to have periaortic hematomas (45% versus 21%, P<0.001). The mortality of patients with pericardial tamponade remained significantly high, even after adjustment for baseline clinical characteristics (44% versus 20%, P<0.001). 47 Thus, its presence should warrant urgent operative intervention.
Periaortic Hematoma
Periaortic hematoma is a complication present in 23% of AAD and is more frequently seen with intramural hematoma than classical dissection. A multivariable model showed that periaortic hematoma is an independent predictor of mortality in patients with AD (OR, 1.71; P=0.007).
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Visceral and Peripheral Ischemia
The mechanisms of visceral and peripheral ischemia may be secondary to severe compression of the true lumen, branch vessel involvement, hypotension, or a combination of these.
Renal Insufficiency
Patients with renal insufficiency (18%) were at increased risk for drug-resistant hypertension and aortic branch vessel compromise (OR, 5.2). This complication was associated with a significant increase in hospital mortality, both in type A (50% versus 25%, P<0.001) and type B (27% versus 9%, P<0.001).
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Mesenteric Malperfusion
Type A AAD complicated by mesenteric malperfusion was a rare (3.7%) but ominous complication carrying a high risk of hospital mortality. 49 In-hospital mortality of patients with mesenteric malperfusion receiving medical, endovascular, or surgical/hybrid therapy was 95%, 73%, and 42%, respectively (P<0.001). IRAD data showed that hybrid management was applied in very few cases and that immediate surgical repair of the proximal dissected aorta still represents the most common therapeutic approach for patients with mesenteric malperfusion. Similarly, visceral ischemia was a complication in 7% of type B AAD and medical management was an independent predictor of mortality in multivariable analysis (OR, 5.91).
Acute Limb Ischemia
Preoperative limb ischemia was reported in 9.7% of the IRAD cohort. 51 This complication was significantly associated with acute renal failure (OR, 2.78), acute mesenteric ischemia/infarction (OR, 6.9), and death (OR, 3.5). Endovascular, but not surgical therapy was more commonly performed in patients with acute limb ischemia (31% versus 10%, P=0.004). Aortic fenestration or aortoiliac stenting was the primary therapy in 93% of these patients; surgical bypass was used in 7%. Limb salvage was achieved in 93% at a mean of 18 months of follow-up. 51 
Brain Injury
Major brain injury at the onset of dissection was a complication in 10% of type A AAD. Arch vessel involvement was more frequent among patients with stroke (68%). 52 Furthermore, arch vessel involvement is associated with 2-or 3-fold higher mortality depending on the presence of cerebrovascular accident or coma, respectively. Even in this cohort, surgery was found to be a protective factor against hospital mortality in patients with preoperative brain injury (OR, 0.058; P<0.001). Medical therapy was associated with dismal outcomes: 100% mortality in patients with coma and 76.2% in those with cerebrovascular accident. Furthermore, return of brain function was frequent after surgery occurring in 84.3% of patients with cardiovascular accident and in 78.8% of those with coma. Therefore, preoperative brain injury should not preclude surgery, which was an independent predictor of survival in this population.
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PREDICTORS OF MORTALITY IN ACUTE PHASE
In-hospital mortality of type A AAD was highly dependent on patient risk profiles before surgery. [54] [55] [56] Patients classified as unstable had much higher in-hospital mortality of 31% versus 17% in those without unstable features (P<0.001) ( Table 2) . 38 Narrow pulse pressure was associated with more cardiac complications, particularly cardiac tamponade, whereas those with markedly elevated pulse pressure were more likely to have abdominal aortic involvement. 57 Independent preoperative predictors of mortality were age >70 years, previous cardiac surgery, 58 hypotension or shock at presentation, migrating pain, cardiac tamponade, any pulse deficit, and an ECG showing findings of myocardial ischemia or infarction. Risk models were created by IRAD to predict in-hospital mortality. 34 Regarding surgical predictors of mortality, more extensive root replacement interventions were not associated with increased hospital mortality. This supports such an approach in young patients and those with connective tissue diseases and bicuspid aortic valves. 59 Therefore, the extent of aortic replacement should remain determined by each patient's clinical and anatomic characteristics, and by the experience of the operating surgeon, as well.
In type B AAD, based on preliminary results, 3 key variables collectively named the deadly triad emerged as highly significant predictors of death: hypotension/ shock, absence of chest/back pain on presentation, and branch vessel involvement. 60 Painless dissection occurred in 4% of patients, and we observed a trend toward increased in-hospital mortality in this group that may result from a delay in diagnosis and management. 61 Mortality in patients with complications (shock, periaortic hematoma, visceral or peripheral ischemia, acute renal failure, recurrent pain, refractory pain, or refractory hypertension) was 20.0% in comparison with 6.1% in patients without complications. 62 A more recent publication including 1035 patients with type B AAD identified the following as predictors of in-hospital mortality in the IRAD: mesenteric ischemia (OR, 9.03), hypotension/shock (OR, 6.43), descending diameter ≥5.5 cm (OR, 6.04), renal failure (OR, 3.61), periaortic hematoma (OR, 3.06), acute limb ischemia (OR, 3.02), and age (OR, 1.03) ( Table 2) . 38, 39 Based on these multivariable results, a reliable and simple bedside risk prediction tool was developed by IRAD.
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MEDIUM-TERM OUTCOME
Across the entire data set, survival for patients with type A AAD treated with surgery was 96.1% and 90.5% 39 copyright © 2014, American Heart Association, Inc.
at 1 and 3 years postdischarge, respectively. Independent predictors of survival during the follow-up period do not appear to be influenced by in-hospital risks but rather by preexisting comorbidities. 63 By contrast, 3-year survival of discharged patients with type B AAD was only 78% in those treated with medical management alone. 64 Independent predictors of follow-up mortality included in-hospital complications: hypotension/shock (hazard ratio [HR], 12.5), renal failure (HR, 2.50), pleural effusion on chest x-ray (HR, 2.56), and clinical factors: a history of previous aortic aneurysm (HR, 2.2), a history of atherosclerosis (HR, 2.48), and female sex (HR, 2.0). 64 In a nonrandomized study, a subgroup of patients with acute type B dissection treated with endovascular repair showed a lower death rate at 5 years (16% versus 29%, P=0.02) in comparison with patients receiving medical therapy alone, despite the initially higher-risk profile attributable to the complicated nature of the patients with dissection undergoing this therapy. 65 These results would suggest that randomized trials comparing best medical therapy plus aortic stent graft treatment with long-term follow-up are needed. Ascending thoracic aortic enlargement in patients with type B AAD is common and associated with more frequent open surgical intervention that often involves replacement of the proximal aorta. 66 Several imaging variables such as aorta size and false lumen flow have been linked to false lumen expansion and mortality. IRAD evaluated the effect of partial false lumen thrombosis and showed it to be present in 33.8% of type B AAD and a significant independent predictor of death at 3 years (HR, 2.7). 67 In contrast, in patients with type A AAD, preoperative false lumen thrombosis did not influence long-term survival. 68 The effects of medication on the outcome of AD remain poorly understood as would be expected from an observational registry. Multivariable models showed the use of β-blockers to be associated with improved survival in patients with type A AAD undergoing surgery (HR, 0.5; P=0.02), and the use of calcium channel blockers was associated with improved survival in patients with type B AAD treated medically (HR, 0.6; P=0.01). 69 In addition, the use of calcium channel blockers after type B AAD may reduce the aortic expansion rate. Aortic expansion during a median follow-up time of 2 years was observed in 59% of patients. The mean annual expansion rate was 1.7±7.6 mm/y. The use of calcium channel blockers was associated with decreased aortic expansion (regression coefficient, -3.8; 95% confidence interval, -6.2 to -1.3; P<0.001). 70 However, all these observations should only be considered as hypothesis generating.
Although the majority of all initial dissections were type A (66%), the majority of recurrent dissections were type B (53%). It is interesting to note that these tendencies were magnified among those with Marfan syndrome, which represented approximately one-fifth of recurrent AD cases. Seventy-nine percent of their initial dissections were type A and 62% of recurrent dissections were type B.
Age at first dissection in patients with recurrent AD is related to the anatomic pattern of aortic disease, with proximal followed by distal AD being more common in the young. In agreement with the 2010 American Heart Association/American College of Cardiology Thoracic Aortic Disease guidelines, 23 we recommend that consideration be given to a formal cardiovascular genetics consultation and gene testing for any patient with recurrent AD, in particular, those who are young and without a history of hypertension, regardless of external physical stigmata of Marfan syndrome.
Alterations in lifestyle and emotional status are frequent in AAD. Severe physical activity restrictions may reduce functional capacity and quality of life in patients post-AAD. 71 Clinicians should screen for unfounded fears after dissection that may reduce quality of life for AAD survivors. 72 A trained physiologist, exercise therapist, or nurse clinician should be available for counseling and supervision, at least during the initial training sessions, and ideally thereafter.
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SPECIAL SUBGROUPS Women
Although less frequently affected by AAD, women with dissection were significantly older than men, with a mean age of 67 years (P=0.008). 74 Women with AAD have different clinical features, which may explain the temporal delay from symptom onset to diagnosis. 74 After adjustment for age and hypertension, women with AD died more frequently than men (OR, 1.4; P=0.04). Type A dissection in women was associated with a higher surgical mortality of 32% versus 22% in men (P=0.013), despite similar delay, surgical technique, and hemodynamics.
Elderly
Almost one-third of patients presenting with AAD were >70 years of age. Typical symptoms and signs of dissection were less common among patients >70. Fewer elderly patients with type A AAD were managed surgically than younger patients (71% versus 89%; P<0.001). 75 Surgical mortality was 21% in patients <70 years of age and 31% in those ≥70 years of age (P=0.003). Surgical management was significantly associated with lower mortality than medical therapy until the age of 80. 76 For those aged 80 to 90 years, in-hospital mortality was also lower after surgical management (37.9% versus 55.2%), but without statistical significance because of limited patient numbers. These data would suggest that surgery should be considered in all patients with type A AAD regardless of age. Simi-larly, older age was an independent predictor of death in type B AAD. In complicated type B AAD, in-hospital mortality rates for patients <70 versus ≥70 years of age were 10.1% versus 30.0% for endovascular treatment (P=0.001), 17.2% versus 34.2% for surgical treatment (P=0.027), and 14.2% versus 32.2% for medical treatment (P=0.001). 77 A classification tree identified risk factors for mortality in elderly patients as hypotension/ shock (56%), 78 any branch vessel involvement (28.6%), and periaortic hematoma (10.5%). In contrast, elderly patients with none of these 3 risk factors had an extremely low mortality rate (1.3%) with type B AAD.
Marfan Syndrome
Patients with Marfan syndrome represented <5% of cases in IRAD. 10 In our registry, these patients presented at the time of AD with larger diameters than patients without Marfan syndrome. They were more likely to dissect at larger diameters (OR, 14.3; P<0.002).
2 With the use of data from IRAD and GenTAC, patients with Marfan syndrome were found to have daily and seasonal variations in the timing of ADs similar to AAD in the general population. 79 Despite their younger age at presentation, patients with Marfan syndrome had a high mortality rate, similar to patients without Marfan syndrome who comprised an older patient cohort. 80 However, patients with Marfan syndrome showed a higher risk of recurrent AD with an HR of 8.6.
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INTRAMURAL HEMATOMA
Intramural hematoma (IMH) is a major type of acute aortic syndrome; 7% of IRAD patients had IMH. 82 This cohort tended to be older (68.7 versus 61.7 years; P<0.001), and these patients were more likely to have distal aortic involvement (60.3% versus 35.3%; P<0.001). The investigators demonstrated an association between the proximity of IMH to the aortic valve and increasing hospital mortality, regardless of medical or surgical treatment. Patients with type A IMH were less likely to present with aortic regurgitation, malperfusion syndrome, or pulse deficits, but they had periaortic hematoma or pericardial effusion more frequently than patients with AAD. IMH required a longer time to diagnosis and more diagnostic tests in comparison with classical dissection.
Like classical AAD, IMH is a highly lethal condition when it involves the ascending aorta with similar mortality (26.5% versus 26.6%, respectively). Type A IMH managed medically has significant mortality (40%), although lower than classical dissection (62%). 83 Patients with type B IMH were older than those with AAD, more often had periaortic hematoma (22% versus 13%; P=0.020), and were more frequently treated medically (88% versus 62%; P<0.001). Hospital mortality was lower than in classical dissection (4.4% versus 11%). 84 Fully 16% of patients have evidence of evolution to dissection on serial imaging.
LIMITATIONS
The participating IRAD centers are tertiary referral hospitals, and thus patients are by definition those who survive to reach such centers. Although participating investigators attempt to include all patients at their institutions, there is no certainty that the registry is representative of all patients with AAD. There is no core laboratory to review images, and all investigators are responsible for reporting patient findings at their institutions. Most of the data regarding patient history and physical examination findings are obtained by retrospective chart review and, consequently, some are lacking. Little information is available regarding cause of death in the IRAD population; therefore, we could not evaluate changes in causes of death over time. This review summarizes findings from articles published using IRAD data at various time points, and did not include any updated analyses on the larger data set.
FUTURE DIRECTIONS
The IRAD has significantly improved the contemporary understanding of AAD and serves as a rich repository for generating sources of new information. IRAD results confirm the need to continue improving the diagnosis and therapeutic management of AAD (Table 3) . Improvement in hospital environment pathways, referring networks, surgical team specialization, and healthcare logistics in terms of shortening times to nonelective surgery may help us to achieve this aim. The problems have been recognized and efforts to improve care are currently being monitored. Future IRAD directions will be to establish new genotype/phenotype correlations in nonsyndromic familial thoracic aortic disease with AAD, identify better predictive tools (imaging and biomarkers) for AAD and late complications after AAD, and define the role of endovascular treatment versus medical treatment in acute and chronic AD settings. In addition, IRAD will branch out into regional activities to enable the comparison of genetic clustering and regional idiosyncrasies and will focus on genetic substudies and regional differences in treatment strategies, as well. Studies to define optimal patient survivorship are also underway.
CONCLUSIONS
In the 20 years since the IRAD was established, overall mortality in patients with type A AAD has declined. It is Many aortas that dissect are smaller than our surgical cutoff points. This argues for better genetic, biomarker, and imaging tests to currently identify patients at risk.
Sudden, instantaneous onset of terrible pain is the key historical feature for early recognition.
ECGs and chest x-rays are less helpful than we thought in terms of early diagnosis.
The International Registry of Acute Aortic Dissection confirms the thoracic aortic disease guideline algorithm for early diagnosis, which is 98% sensitive if one adds aortic dilation on chest x-rays.
The International Registry of Acute Aortic Dissection offers a new classification for time from symptom onset into hyperacute, acute, subacute, and chronic phases.
d-Dimer is a highly sensitive biomarker; now we need a specific one to add to it in a dual biomarker platform.
Type A mortality is falling as surgeons and aortic centers take on more complicated and older patients.
Type B mortality has been stable, but thoracic endovascular aortic repair is replacing surgery for complicated disease. Time will tell whether it reduces late aortic complications and death.
False channel partial thrombosis appears to be a negative prognostic marker in type B aortic dissection and calls to mind the need to learn more from imaging.
Intramural hematoma in the ascending aorta is a nasty disease that mirrors acute type A.
The aortic arch remains half-way between A and B, and its optimal management therefore is an area of continued uncertainty.
IMH indicates intramural hematoma; IRAD, International Registry of Acute Aortic Dissection; TAD, thoracic aortic disease; and TEVAR, thoracic endovascular aortic repair.
